{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T17:36:07Z","timestamp":1758476167273},"reference-count":0,"publisher":"BMJ","issue":"17","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1136\/heartjnl-2017-311331","type":"journal-article","created":{"date-parts":[[2017,4,5]],"date-time":"2017-04-05T00:41:01Z","timestamp":1491352861000},"page":"1310-1312","update-policy":"http:\/\/dx.doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Angiotensin-converting enzyme inhibitors versus receptor blockers: is one better than the other for cardiovascular prevention?"],"prefix":"10.1136","volume":"103","author":[{"given":"Yutaka","family":"Furukawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2017,4,4]]},"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2017-311331","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T18:16:04Z","timestamp":1601057764000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2017-311331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,4]]},"references-count":0,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2017,8,15]]},"published-print":{"date-parts":[[2017,9]]}},"alternative-id":["10.1136\/heartjnl-2017-311331"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2017-311331","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,4]]}}}